Adage Capital Partners Gp, L.L.C. Ionis Pharmaceuticals Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,800,000 shares of IONS stock, worth $262 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
3,800,000
Previous 1,075,600
253.29%
Holding current value
$262 Million
Previous $32.5 Million
362.67%
% of portfolio
0.27%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding IONS
# of Institutions
414Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.15 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.11 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$866 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$712 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$542 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $9.8B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...